Transluminal gene transfer into brain capillary endothelial cells in vivo with HVJ-liposomes.

Chen Jiang,Hirotami Matsuo,Noriko Koyabu,Hisakazu Ohtani,Hidenori Fujimoto,Yoshikazu Yonemitsu,Yasufumi Kaneda,Mikihiko Narro,Takashi Tsuruo,Yasufumi Sawada
DOI: https://doi.org/10.1080/10611860290031822
2008-01-01
Journal of Drug Targeting
Abstract:Bioactive proteins or peptides cannot be effectively delivered into brain capillary endothelial cells (BCECs) or brain parenchyma. In this study, we selectively transferred Escherichia coli beta-galactosidase gene (beta-gal) as a model gene into BCECs by using the hemagglutination virus of Japan (HVJ)-liposomes. HVJ-Iiposomes encapsulating a beta-gal plasmid were used to transfect MBEC4 cells in vitro, and were administrated via the internal carotid artery to rat in vivo. Success of the procedure was confirmed by the detection of 116 kDa beta-gal protein in transfected MBEC4 cells and in brain capillaries isolated from transfected rats, by Western blot analysis and histological staining. The enzymatic activities of beta-galactosidase were 5- to 10-fold and 20-fold higher than when beta-gal-containing liposomes without fusogenic activity (uncoated liposomes) or plasmid alone were employed in vitro and in vivo, respectively. Thus, HVJ-Iiposomes were demonstrated to be a useful hector to transfer a foreign gene into the brain capillary endothelium in vivo via the transluminal route.
What problem does this paper attempt to address?